Here are the 424B prospectus supplements from DSS, Inc. (DSS) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow DSS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DSS filings page.
DSS, Inc. (DSS) has filed a prospectus supplement for a primary offering of common stock and accompanying pre-funded warrants under its $10,000,000 shelf registration. The pre-funded warrants carry a de minimis exercise price of $0.00001 per share and are structured with ownership caps to limit any holder’s post-exercise beneficial ownership to 4.99% or, at the holder’s election, 9.99% of outstanding common stock.
The company’s public float, calculated under Form S-3 General Instruction I.B.6, is about $3.31 million based on 3,898,854 non‑affiliate shares at $0.85 per share as of September 3, 2026, and DSS states it has not used this S-3 capacity in the prior 12 months. DSS plans to use net proceeds, together with existing cash, for capital expenditures, operations, marketing, investments in existing initiatives and products, potential acquisitions, and general working capital. The filing highlights that investors in this offering will experience immediate and potentially substantial dilution and may face further dilution from future equity issuances and outstanding equity awards.
DSS, Inc. is conducting a primary offering of 900,000 shares of common stock at $1.00 per share, with an underwriter over‑allotment option for up to 135,000 additional shares. Gross proceeds are $900,000, with estimated net proceeds of about $677,000 after underwriting fees and expenses.
Shares outstanding are expected to increase from 9,092,518 to 9,992,518, or up to 10,127,518 if the over‑allotment is fully exercised. The company plans to use roughly $100,000 of the net proceeds for capital expenditures and about $577,000 for general corporate and working capital needs, which may include officer compensation.
The prospectus highlights significant secured indebtedness, including loans that are in default and past due, concentration of revenue in two major customers, prior material weaknesses in internal controls, potential impairment of sizable intangible assets, and the risk of NYSE American delisting, all of which could pressure future results and liquidity.